Malignant Skin Neoplasm — Trials

Malignant Skin Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,248 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 320
Recruiting: 171
Ph III recruiting: 11
Growth YoY: +11.1%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (202)

clinicaltrialsPublishedShowing 1–50 of 126 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04577755	Pomalidomide Treatment in Patients With Kaposi Sarcoma	active not recruiting	Phase 2	45	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials
NCT04387084	Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy	active not recruiting	Phase 1	10	University of Southern CaliforniaOTHER	1	Sep 21, 2026	clinicaltrials